Last reviewed · How we verify

NCT04137367

A Personalized Approach to Effects of Affective Bias Modification on Symptom Change and Rumination

Completed NA Results posted Last updated 5 February 2025
What this trial tests

NA trial testing Affective bias modification in Major Depressive Disorder in 108 participants. Completed in 3 April 2022.

Timeline
19 November 2019
Primary endpoint
3 April 2022
3 April 2022

Quick facts

Lead sponsorUniversity of Oslo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment108
Start date19 November 2019
Primary completion3 April 2022
Estimated completion3 April 2022
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

University of Oslo

Who can join

Adults 18 to 65, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Self-reported Depressive Symptoms: Becks Depression Inventory-II Primary · At 6 months follow-up

Self-reported depressive symptoms 6 months after the ABM intervention based on a 21-item scale. Each item is scored 0-3 (where scoring description is adapted to each item), yielding a score from 0-63.

GroupValue95% CI
Active Affective Bias Modification19.1± 1.7
Sham Affective Bias Modification16.5± 1.6
Assessment Only5.3± 5.5
State Rumination: Brief State Rumination Inventory (BSRI) Primary · At baseline and two weeks follow up.

Change in self-reported state rumination after the stress induction from pre to post intervention on a 8 item scale. Difference score: BSRI post intervention - BRSI Baseline. A negative score means reduction in state rumination over the intervention. Each item is scored on a 0-100 Visual Analogue Scale. The total score divided by 8 to provide the mean item total score, hence the min= 0 and max = 100 for each of the BSRI assessment time points. It was hypothesized that change in state rumination over the intervention period would mediate the effect of ABM on depressive symptoms at six months fo

GroupValue95% CI
Active Affective Bias Modification-.7± 13.3
Sham Affective Bias Modification-5.8± 19.1
Assesment Only-.8± 7.4
State Rumination: Brief State Rumination Inventory Primary · At two weeks follow up.

Self-reported state rumination after stress induction on a 8 item scale. Each item is scored on a 0-100 Visual Analogue Scale, yielding a score from 0-800, which is reported divided by 8 to provide a mean total item score. Hence the min= 0 and max = 100. A higher score indicates more state rumination.

GroupValue95% CI
Active Affective Bias Modification34.2± 15.8
Sham Affective Bias Modification32.3± 15.8
Assessment Only23.4± 20.2
Affective Bias: Dot-probe Task Secondary · From baseline to two weeks follow up

Change in reaction time in milliseconds to probes in the location of the positive facial stimuli compared to probes in the location of the negative stimuli. Positive number implies reduction in negative bias.

GroupValue95% CI
Active Affective Bias Modification18.0± 28.4
Sham Affective Bias Modification9.4± 40.3
Symptom Network Change: Experience Sampling of Depressive Symptoms Secondary · From two weeks prior to baseline to two weeks after the two-week intervention.

Changed centrality of rumination in networks estimated based on a 9-item experience sampling questionnaire of self-reported depressive symptoms scored on a 0-100 visual analogue scale (higher value, more symptoms; reversing interest, positive affect and activity; Kraft et al., 2023, Psychiatry Research Communications). Two person-specific networks (pre and post-intervention) were estimated using the var1-function in the R package psychonetrics, with full-information maximum likelihood estimator, based on the experience sampling questionnaires that were administrated 5 times/day for 14 days bef

GroupValue95% CI
Active Affective Bias Modification.0175± .0819
Sham Affective Bias Modification-.685± .789
Symptom Network: Experience Sampling of Depressive Symptoms Secondary · Two weeks after the two-week intervention.

Centrality of rumination in networks based on a 9-item experience sampling questionnaire of self-reported depressive symptoms scored on a 0-100 visual analogue scale (higher value, more symptoms; reversing interest, positive affect and activity; Kraft et al., 2023, Psychiatry Research Communications). Person-specific networks were estimated using the var1-function in the R package psychonetrics, with full-information maximum likelihood estimator, based on the experience sampling questionnaires that were administrated 5 times/day for 14 days after the two-week intervention. Centrality of rumina

GroupValue95% CI
Active Affective Bias Modification.108± .785
Sham Affective Bias Modification-.230± .824

Sponsor's own description

This study evaluates the effect of a computerized intervention for depressive symptoms called Affective Bias Modification (ABM). A third of the patients will receive active ABM, a third will receive sham ABM and a third will undergo assessment only. The study will investigate if rumination mediates the effect of the intervention and investigate if specific symptom profiles affect the effect of the intervention.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The effect of attention bias modification on depressive symptoms in a comorbid sample: a randomized controlled trial.
    Bø R, Kraft B, Pedersen ML, Joormann J, et al · · 2023 · cited 5× · PMID 36617964 · DOI 10.1017/s0033291722003956
  2. Cognitive predictors of stress-induced mood malleability in depression.
    Bø R, Kraft B, Joormann J, Jonassen R, et al · · 2024 · cited 3× · PMID 37695740 · DOI 10.1080/10615806.2023.2255531
  3. The effect of ABM on attentional networks and stress-induced emotional reactivity in a mixed clinical sample with depression: A randomized sham-controlled trial.
    Bø R, Kraft B, Jonassen R, Joormann J, et al · · 2024 · PMID 40656096 · DOI 10.1016/j.nsa.2024.104091

Verify or expand the search:

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

Other University of Oslo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04137367.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing